Kaisa Health Group Holdings Limited (0876.HK)
HKD 0.03
(0.0%)
HKD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 27.56 Million HKD | 26.81% |
| 2022 | -132.02 Million HKD | -53.8% |
| 2021 | 45.57 Million HKD | 55.12% |
| 2020 | -20.7 Million HKD | -172.08% |
| 2019 | -347.56 Million HKD | 17.56% |
| 2018 | -11.45 Million HKD | -1778.16% |
| 2017 | -1.32 Million HKD | -123.12% |
| 2016 | 5.72 Million HKD | 243.76% |
| 2015 | -2.28 Million HKD | 91.83% |
| 2014 | -96.29 Million HKD | -369.9% |
| 2013 | -799 Thousand HKD | -74.07% |
| 2012 | 68.99 Million HKD | -65.69% |
| 2011 | 58.71 Million HKD | 85.2% |
| 2010 | 108.83 Million HKD | 29.28% |
| 2009 | 84.8 Million HKD | 105.04% |
| 2008 | -44.64 Million HKD | -56.63% |
| 2007 | 113.84 Million HKD | 29.78% |
| 2006 | 73.47 Million HKD | -5.01% |
| 2005 | 77.35 Million HKD | 6.37% |
| 2004 | 72.72 Million HKD | 86.31% |
| 2003 | 39.03 Million HKD | 111.3% |
| 2002 | 18.47 Million HKD | 158.34% |
| 2001 | -31.66 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.89 Million HKD | 0.0% |
| 2023 FY | - HKD | 26.81% |
| 2023 Q4 | -20.17 Million HKD | 0.0% |
| 2023 Q2 | -7.98 Million HKD | 0.0% |
| 2022 FY | - HKD | -53.8% |
| 2022 Q2 | -27.9 Million HKD | 0.0% |
| 2022 Q4 | -10.57 Million HKD | 0.0% |
| 2021 Q2 | 17.74 Million HKD | 0.0% |
| 2021 Q4 | -42.75 Million HKD | 0.0% |
| 2021 FY | - HKD | 55.12% |
| 2020 Q2 | -16.15 Million HKD | 0.0% |
| 2020 FY | - HKD | -172.08% |
| 2020 Q4 | -39.58 Million HKD | 0.0% |
| 2019 Q2 | -5.61 Million HKD | 0.0% |
| 2019 Q4 | -14.87 Million HKD | 0.0% |
| 2019 FY | - HKD | 17.56% |
| 2018 FY | - HKD | -1778.16% |
| 2018 Q4 | -29.64 Million HKD | 0.0% |
| 2018 Q2 | 4.79 Million HKD | 0.0% |
| 2017 Q2 | 5.76 Million HKD | 0.0% |
| 2017 FY | - HKD | -123.12% |
| 2016 Q2 | 11.24 Million HKD | 0.0% |
| 2016 FY | - HKD | 243.76% |
| 2015 FY | - HKD | 91.83% |
| 2015 Q2 | -29.67 Million HKD | 0.0% |
| 2014 Q2 | -10.78 Million HKD | 0.0% |
| 2014 Q4 | -37.97 Million HKD | 0.0% |
| 2014 FY | - HKD | -369.9% |
| 2013 FY | - HKD | -74.07% |
| 2013 Q2 | 8.67 Million HKD | 0.0% |
| 2013 Q4 | 9.38 Million HKD | 0.0% |
| 2012 Q1 | 89.93 Million HKD | 0.0% |
| 2012 Q4 | 1.91 Million HKD | -97.87% |
| 2012 Q3 | 89.93 Million HKD | 0.0% |
| 2012 Q2 | 89.93 Million HKD | 0.0% |
| 2012 FY | - HKD | -65.69% |
| 2011 Q1 | 51.21 Million HKD | 0.0% |
| 2011 Q2 | 51.21 Million HKD | 0.0% |
| 2011 Q3 | 51.21 Million HKD | 0.0% |
| 2011 FY | - HKD | 85.2% |
| 2011 Q4 | 89.93 Million HKD | 75.61% |
| 2010 FY | - HKD | 29.28% |
| 2010 Q1 | 27.46 Million HKD | 0.0% |
| 2010 Q4 | 51.21 Million HKD | 86.44% |
| 2010 Q3 | 27.46 Million HKD | 0.0% |
| 2010 Q2 | 27.46 Million HKD | 0.0% |
| 2009 Q1 | 21.45 Million HKD | 0.0% |
| 2009 Q2 | 21.45 Million HKD | 0.0% |
| 2009 Q4 | 27.46 Million HKD | 28.01% |
| 2009 Q3 | 21.45 Million HKD | 0.0% |
| 2009 FY | - HKD | 105.04% |
| 2008 Q1 | -11.07 Million HKD | 0.0% |
| 2008 FY | - HKD | -56.63% |
| 2008 Q4 | 21.45 Million HKD | 293.8% |
| 2008 Q3 | -11.07 Million HKD | 0.0% |
| 2008 Q2 | -11.07 Million HKD | 0.0% |
| 2007 FY | - HKD | 29.78% |
| 2007 Q4 | -11.07 Million HKD | -146.2% |
| 2007 Q3 | 23.96 Million HKD | 0.0% |
| 2007 Q1 | 23.96 Million HKD | 0.0% |
| 2007 Q2 | 23.96 Million HKD | 0.0% |
| 2006 Q1 | 18.37 Million HKD | 0.0% |
| 2006 FY | - HKD | -5.01% |
| 2006 Q4 | 23.96 Million HKD | 30.4% |
| 2006 Q3 | 18.37 Million HKD | 0.0% |
| 2006 Q2 | 18.37 Million HKD | 0.0% |
| 2005 Q1 | 19.33 Million HKD | 0.0% |
| 2005 Q4 | 18.37 Million HKD | -4.97% |
| 2005 Q3 | 19.33 Million HKD | 0.0% |
| 2005 Q2 | 19.33 Million HKD | 0.0% |
| 2005 FY | - HKD | 6.37% |
| 2004 Q2 | 21.44 Million HKD | 0.0% |
| 2004 FY | - HKD | 86.31% |
| 2004 Q3 | 21.44 Million HKD | 0.0% |
| 2004 Q4 | 19.33 Million HKD | -9.81% |
| 2004 Q1 | 21.44 Million HKD | 0.0% |
| 2003 Q2 | 12.11 Million HKD | 0.0% |
| 2003 Q1 | 12.11 Million HKD | 0.0% |
| 2003 FY | - HKD | 111.3% |
| 2003 Q4 | 21.44 Million HKD | 76.97% |
| 2003 Q3 | 12.11 Million HKD | 0.0% |
| 2002 Q2 | 7.57 Million HKD | 0.0% |
| 2002 Q4 | 12.11 Million HKD | 59.9% |
| 2002 Q3 | 7.57 Million HKD | 0.0% |
| 2002 Q1 | 7.57 Million HKD | 0.0% |
| 2002 FY | - HKD | 158.34% |
| 2001 FY | - HKD | 0.0% |
| 2001 Q4 | 7.57 Million HKD | 221.22% |
| 2001 Q3 | -6.25 Million HKD | 0.0% |
| 2001 Q1 | -6.25 Million HKD | 0.0% |
| 2001 Q2 | -6.25 Million HKD | 0.0% |
| 2000 Q4 | -6.25 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Elegance Optical International Holdings Limited | -51.64 Million HKD | 153.365% |
| Arts Optical International Holdings Limited | 77.08 Million HKD | 64.247% |
| Kelfred Holdings Limited | 14.24 Million HKD | -93.492% |
| Modern Dental Group Limited | 696.64 Million HKD | 96.044% |